About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 673186, 6 pages
http://dx.doi.org/10.1155/2012/673186
Research Article

Is the BCG Vaccine Safe for Undernourished Individuals?

Departamento de Microbiologia e Imunologia, Instituto de Biociências, Universidade Estadual Paulista (UNESP), 18618-970 Botucatu, SP, Brazil

Received 8 December 2011; Accepted 11 February 2012

Academic Editor: Enrico Maggi

Copyright © 2012 Larissa Lumi Watanabe Ishikawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Cellular immunity is critical for protection against tuberculosis, but its integrity is compromised during undernutrition. The present study was designed to evaluate if the attenuated mycobacterium BCG is a safe vaccine for undernourished individuals. An experimental model of undernutrition was established by subjecting BALB/c mice to dietary restriction. These animals received 70% of the amount of food consumed by the healthy control group and exhibited physiological alterations compatible with malnutrition, including body weight loss, reduced levels of triglycerides and glucose, and reduced lymphocyte numbers. Undernourished mice were immunized with BCG, and the mycobacterial loads in lymph nodes, spleen, liver, lungs, and thymus were determined. A much higher proportion of undernourished mice exhibited bacterial dissemination to the lymph nodes, spleen and liver. In addition, only undernourished animals had bacteria in the lungs and thymus. Concomitant with higher mycobacterial loads and more widespread BCG dissemination in undernourished mice, production of TNF-α, IFN-γ, and IL-10 was also diminished in these mice. Taken together, these results indicate that BCG infection is more severe in undernourished mice. Whether a similar phenomenon exists in undernourished children or not remains to be thoroughly investigated.

1. Introduction

Undernutrition is one of the major causes of mortality and morbidity worldwide. Latest estimates indicate that over 800 million people in the world are undernourished [1]. Poverty and lack of adequate sanitary conditions contribute to a higher prevalence of malnutrition in underdeveloped countries. Protein-energy malnutrition (PEM) is the most common type of undernutrition and is caused by deficiencies in protein or macro- and micronutrients such as vitamin A, vitamin E, vitamin B6, folate, zinc, iron, copper, and selenium [2]. Inadequate energy intake leads to various physiological deficiencies, such as growth deficiencies and loss of fat, muscle and visceral mass, and has deleterious effects on the immune system [3]. Undernutrition has been linked to many deficiencies of the innate immunity as decreased lysozyme production by monocytes and polymorphonuclear cells (PMNs), depletion of complement components, and impairment of macrophage functions [4]. Adaptive immunity is also compromised during nutritional depletion. PEM impairs, for example, cytokine production, T-cell function, and the ability of lymphocytes to appropriately respond to these cytokines [5].

The most immediate consequence of undernutrition is increased susceptibility to infections. Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis that has historically been known to be influenced by undernutrition. It is the major cause of morbidity and mortality in developing countries where malnutrition is also prevalent [6]. It is also well established that the cellular immune response, whose efficacy is compromised during undernutrition, is required to protect against TB. The only available vaccine against TB is the attenuated Mycobacterium bovis Bacillus Calmette-Guérin (BCG) that is recommended by the World Health Organization for all infants under one year of age. Around 100 million newborn children are given this vaccine, and the global vaccine coverage is estimated to be 80% [7]. Regardless, large numbers of well-documented trials show extensive variation in the protective efficacy of BCG, ranging from 0 to 80% [8]. Although the overall efficacy is low, most studies agree that BCG protects against disseminated disease in newborns and children but that this immunity wanes with age, resulting in no or insufficient protection against adult pulmonary TB [9, 10]. For this reason, there is great interest in developing new vaccines to prevent TB infection. A number of alternative living and nonliving TB vaccines, including genetic vaccines, are currently being investigated [1113]. For example, DNAhsp65 is a genetic vaccine containing the gene of mycobacterial 65 kDa heat shock protein that has also been used in prime-boost protocols as an attempt to improve BCG efficacy. Safe and effective heterologous prime-boost regimens that augment BCG or recombinant BCG immunization are considered the most realistic strategies for TB control [10]. We previously reported that both DNAhsp65 and BCG could prime newborn mice for stronger immune responses to DNAhsp65 boosters at the adult stage [13]. Prime-boost strategies combining these two vaccines were also able to protect well-nourished mice and guinea pigs against TB infection [14, 15]. More recently, we demonstrated that the antibody induction by the same genetic vaccine (DNAhsp65) was abrogated in animals submitted to dietary restriction [16]. We also observed that immunization with formalized Staphylococcus aureus protected well-nourished mice but not undernourished ones from lung injury in methicilin-resistant S. aureus infection [17].

The present study was designed to compare BCG dissemination and load between well-nourished and undernourished mice.

2. Materials and Methods

2.1. Animals

Four- to five-week-old isogenic female BALB/c mice were housed in plastic cages with white wood chips for bedding, free access to filtered water, and conditions of controlled lighting (12 h light/12 h dark cycle) and temperature ( °C). After weaning, mice were acclimated on standard chow for 10 days (Purina, Paulínia, SP, Brazil). This animal chow is considered adequate for mice and it is officially approved by the Brazilian Ministry of Agriculture (SP-0311730758). Animals were manipulated in compliance with the ethical guidelines adopted by the Brazilian College of Animal Experimentation, and the experimental protocol used in this work was approved by the local ethics committee (19/08-CEEA).

2.2. Experimental Design

We initially analyzed physical, hematological, biochemical, and immunological parameters associated with 10 days of undernutrition. For this, mice were allocated into two experimental groups: the control group (normal) and the undernourished one (restricted). The first one was fed ad libitum and the second one received only 70% of the amount of food consumed by the control group. Bacterial loads and cytokine production were then compared in normal and undernourished mice intradermally inoculated with BCG (105 CFU) at the base of the tail. Immunization of the undernourished group was delivered at the day 10 after the beginning of dietary restriction. The evaluations were performed 25 days after the beginning of food restriction. In the aforementioned evaluations, both experimental groups were housed in a ventilated caging system. To test the effect of household contact, normal and undernourished nonimmunized mice were also housed in conventional open cages, in the same room of immunized animals, before determination of bacterial loads in different organs.

2.3. Hematological and Biochemical Parameters

Blood samples were collected by retro-orbital puncture and directly examined for hematological analysis or centrifuged for sera separation. Total leukocyte numbers were determined after blood dilution in Turk’s solution, and differential leukocyte count was performed in blood smear stained with eosin/methylene blue (Leishman’s stain). Blood glucose level was measured with Prestige Smart System (Home Diagnostics, FL, USA). Total protein, albumin, triglycerides and cholesterol in serum samples were measured by biuret, bromocresol green, and enzymatic Trinder standard methods, respectively (Labtest Diagnóstica SA, Belo Horizonte, MG, Brazil).

2.4. Cytokine Production

Murine spleens were removed, disrupted, and filtered in nylon cell strainers (Becton Dickinson, Franklin Lakes, NJ, USA). Splenocytes were resuspended in RPMI 1640 medium (Cultilab, Campinas, SP, Brazil) and then centrifuged (10 min, 1500 rpm, 4°C). Splenocytes were resuspended in RPMI medium supplemented with 10% fetal calf serum, 2 mM L-glutamine and 40 mg/mL gentamicin. Cells were plated at cells/mL in 48-well flat-bottomed culture plates (Nunc) and stimulated with 10 μg/mL of recombinant heat shock protein 65-kDa (rhsp65) or 10 μg/mL of concanavalin A (ConA) type IV-S (Sigma, St. Louis, MO, USA). Cytokine levels were evaluated 48 h later by enzyme-linked immunosorbent assay (ELISA) in culture supernatants using IFN-γ and IL-10 BD OptEIA Sets (Becton Dickinson) and TNF-α Duoset (R&D Systems, Minneapolis, MN, USA). The assays were performed according to the manufacturer’s instruction.

2.5. Tissue Bacterial Loads

Thymus, inguinal and popliteal lymph nodes, spleen, lungs, and liver from each mouse were collected and homogenized in 1 mL of saline. Next, 100 μL of organ homogenates was plated in 7H11 mycobacteria agar and incubated at 37°C. After 30 days, Mycobacterium bovis colony forming units (CFUs) were counted.

2.6. Statistical Analysis

Statistical analyses were performed using SigmaPlot (Systat Software, CA, USA). Body weight was analyzed by paired -test. All experiments related to BCG immunization were analyzed by one-way ANOVA parametric test or Kruskal-Wallis nonparametric test followed by comparative Dunn’s test. Other results were analyzed by unpaired -test. values < 0.05 were considered statistically significant.

3. Results

3.1. Alterations Induced by Experimental Undernutrition

Physical, hematological, biochemical, and immunological alterations possibly triggered by malnutrition were determined 10 days after the beginning of dietary restriction. At this time, body weight was already significantly lower in comparison to the normal group. Levels of triglycerides and glucose were also significantly below normal levels. Number of lymphocytes, PMNs, and monocytes in the undernourished group were all significantly lower than in normal animals. By this time, the production of IFN-γ, TNF-α, and IL-10 by spleen cells stimulated with ConA was similar in the two experimental groups. These results are shown in Table 1.

tab1
Table 1: Physical, hematological, biochemical, and immunological parameters in undernourished BALB/c mice. Body weight was recorded daily and the other parameters were evaluated on day 10 after the beginning of dietary restriction. Values represent mean ± standard deviation of 6 animals.
3.2. BCG Dissemination and Load in Undernourished Mice

Fifteen days after subcutaneous BCG immunization, normal and undernourished mice were euthanized and bacterial loads in secondary lymphoid organs, liver, lungs and thymus were assessed. As expected, bacteria were not recovered from nonimmunized animals. However, striking differences were observed between normal and undernourished mice immunized with BCG. A much higher proportion of undernourished mice exhibited bacterial dissemination to lymph nodes, spleen, and liver, and only undernourished animals had bacteria in the lungs and thymus. Interestingly, BCG was recovered from undernourished but not from well-nourished household contacts (Table 2). Levels of bacilli recovered from lymph nodes and thymus of undernourished animals are illustrated in Figure 1.

tab2
Table 2: Number of colonized BALB/c mice after BCG immunization. (A) Percentage of colonization in the lymph nodes, spleen, liver, lungs and thymus of normal immunized mice. (B) Percentage of colonization in different organs of animals immunized with BCG after 10 days of dietary restriction. (C) Percentage of colonization in different organs of household contacts (nonimmunized undernourished mice housed in conventional open cages allocated in the same room of immunized animals).
673186.fig.001
Figure 1: Effect of undernutrition on BCG dissemination. BALB/c mice were submitted to 10 days of dietary restriction and then immunized with BCG. Bacilli were recovered from the lymph nodes and thymus 15 days after BCG immunization. CFU values represent mean ± standard deviation of 6–10 animals.
3.3. Effect of Undernutrition and BCG on Cytokine Production

Cytokine production was significantly affected by both undernourishment and BCG immunization. Spleen cells from undernourished mice produced less IFN-γ in response to rhsp65 stimulation than well-nourished animals. These cells also produced less IFN-γ after ConA addition. In normal mice, but not in undernourished ones, BCG immunization was associated with higher production of IFN-γ, TNF-α, and IL-10 by spleen cells stimulated with rhsp65 (Figure 2).

673186.fig.002
Figure 2: Effect of undernutrition on cytokine production by BALB/c mice immunized with BCG. Splenic cells were stimulated with rhsp65 or ConA, and IFN-γ, TNF-α, and IL-10 production were measured by ELISA. Evaluations were performed 25 days after the beginning of dietary restriction, that is, 15 days after BCG immunization. Values represent mean ± standard deviation of 6-7 animals. * .

4. Discussion

Experimental dietary restriction is being used to explore the effects of PEM on immunity and susceptibility to infectious agents [18]. However, no study to date has evaluated the effect of undernutrition on susceptibility to attenuated vaccines that could theoretically behave as virulent pathogens. We first characterized the malnourished state in a mouse model and determined its effect on BCG dissemination and load. The immunological alterations triggered by undernutrition and the effect of BCG on cytokine production in undernourished mice were also evaluated. BCG was intradermally injected after 10 days of dietary restriction when several changes were already evident. Body weight, number of total leukocytes, PMNs, and lymphocytes, and serum levels of glucose and triglycerides were all below normal levels in undernourished animals by this time point.

Bacilli amount was determined in lymph nodes, spleen, thymus, and liver to compare the severity of BCG infection. The percentage of animals from which bacilli were recovered considering all evaluated organs was always much higher in the undernourished group. In addition, no bacteria were able to spread to the lungs and thymus in well-nourished mice, whereas bacilli recovery in the lungs and thymus of undernourished ones occurred in 50% and 82% of the animals, respectively. Another indication that BCG infection was more severe in undernourished mice was revealed by BCG loads in different organs. A significantly higher amount of bacilli was detected in the lymph nodes and thymus of undernourished immunized mice in comparison to their well-nourished counterparts. In contrast, there was no difference in BCG loads in the spleen, and liver of undernourished compared to well-nourished mice (data not shown).

An additional experiment was performed to compare the effect of household contact between healthy and undernourished mice. No bacilli were recovered from well-nourished nonimmunized mice housed in the same environment as well-nourished BCG-immunized mice. In contrast, BCG was detected in the lymph nodes, spleen and liver of some undernourished nonimmunized household contacts, as shown in Table 2. This finding deserves further investigation and is relevant for undernourishment in household contacts, especially in the case of TB and attenuated viral and bacterial vaccines. Severe malnutrition is described as an important risk factor for the transmission of infections to children in household contact with adults with pulmonary TB [19].

To the best of our knowledge, this is the first report describing the effect of BCG in experimental undernutrition. Two points related to these findings deserve special attention. The first one relates to the efficacy of BCG and its potential to trigger disseminated BCG infection (BCGosis) in undernourished children. Children with severe combined immunodeficiency can develop BCGosis after BCG immunization as a result of their deficient immune system, which clearly illustrates that vaccinations should only be performed in immunocompetent individuals [20]. The second point relates to the immunological consequences of BCG presence in the thymus of undernourished mice. Only a few reports have analyzed mycobacterial colonization in the murine thymus. Nobrega et al. reported that colonization of the thymus by BCG was delayed and occurred at a time when bacterial load was already decreasing in other organs [21]. Our results showed that BCG colonized the thymus of undernourished immunized mice at an early time point, that is, 15 days after BCG inoculation, whereas no mycobacteria was detected in the thymus of well-nourished mice. Future investigations should clarify whether the presence of mycobacteria can influence thymic selection and consequently affect the course of mycobacterial or other infectious diseases. Interestingly, a recent report demonstrated that mycobacteria dissemination to the thymus rendered newly generated T cells tolerant to the invading pathogen [22].

Analysis of cytokine production 15 days after BCG immunization (25 days after the beginning of dietary restriction) indicated that splenocytes from malnourished mice were deficient in their ability to produce IFN-γ in response to both specific (rhsp65) and policlonal (ConA) stimuli. In addition, splenocytes from healthy but not undernourished animals immunized with BCG produced significant levels of IFN-γ, TNF-α, and IL-10 in response to in vitro stimulation with rhsp65. This lower production of TNF-α and IFN-γ by undernourished mice could explain the higher BCG load in these animals, as these cytokines are known to activate macrophages to restrain mycobacterial growth [23, 24]. Similarly, lower production of these cytokines associated with undernutrition could facilitate BCG dissemination to the thymus and lungs in these animals. Even though the extent of protection afforded by BCG is highly debated, the consensus is that this vaccine is able to protect children against more severe forms of TB infections [25] and leprosy [26] and may also offer nonspecific protection against other infectious diseases [27]. Undernutrition could, therefore, severely undermine all these protective effects associated with BCG.

As we mentioned before, IL-10 production was also clearly affected by undernutrition. Whereas normal mice produced significant higher levels of this cytokine after BCG immunization, there was no IL-10 upregulation in undernourished mice. It is tempting to speculate that the immunoregulatory properties of BCG in autoimmunity and allergies are related to IL-10 production and are consequently lost in undernourished individuals. Evidence of the immunoregulatory effects of BCG in healthy animals has been described. Sewell et al. observed that Schistosoma mansoni OVA pretreatment, BCG infection, and lyophilized M. tuberculosis all decreased clinical manifestations of experimental autoimmune encephalomyelitis in mice [28]. Interestingly, this immunoregulatory activity has been associated with IL-10 production by regulatory Th17 cells [29] and dendritic cells [30].

5. Conclusions

Taken together, these results raise questions regarding the safety and efficacy of BCG vaccination in undernourished children. For instance, it will be important to assess whether these children develop BCGosis. Studies of the protective effects of BCG against leprosy and more severe forms of TB are also essential. Finally, the potential loss of the ability of BCG to downregulate deleterious immune responses associated with autoimmunity and allergy and the consequences of BCG dissemination to the thymus in undernourished individuals also deserve further investigation.

Acknowledgments

The authors are grateful to Secretaria da Saúde do Estado de São Paulo for providing BCG and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) that supported this study with a grant.

References

  1. Food and Agriculture Organization of the United Nations (FAO), “Economic crisis: impacts and lessons learned,” in The State of Food Insecurity in the World 2009, FAO, Rome, Italy, 2009.
  2. S. Cunningham-Rundles, D. F. McNeeley, and A. Moon, “Mechanisms of nutrient modulation of the immune response,” Journal of Allergy and Clinical Immunology, vol. 115, no. 6, pp. 1119–1129, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. Grover and L. C. Ee, “Protein energy malnutrition,” Pediatric Clinics of North America, vol. 56, no. 5, pp. 1055–1068, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. R. K. Chandra, “Nutrition and immunoregulation. Significance for host resistance to tumors and infectious diseases in humans and rodents,” Journal of Nutrition, vol. 122, no. 3, pp. 754–757, 1992. View at Scopus
  5. G. Dai and D. N. McMurray, “Altered cytokine production and impaired antimycobacterial immunity in protein-malnourished guinea pigs,” Infection and Immunity, vol. 66, no. 8, pp. 3562–3568, 1998. View at Scopus
  6. D. E. Griffith and C. M. Kerr, “Tuberculosis: disease of the past, disease of the present,” Journal of Perianesthesia Nursing, vol. 11, no. 4, pp. 240–245, 1996. View at Scopus
  7. P. Andersen and T. M. Doherty, “The success and failure of BCG—implications for a novel tuberculosis vaccine,” Nature Reviews Microbiology, vol. 3, no. 8, pp. 656–662, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. G. A. Colditz, T. F. Brewer, C. S. Berkey et al., “Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature,” Journal of the American Medical Association, vol. 271, no. 9, pp. 698–702, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. P. E. M. Fine, “Variation in protection by BCG: implications of and for heterologous immunity,” Lancet, vol. 346, no. 8986, pp. 1339–1345, 1995. View at Scopus
  10. Y. A. W. Skeiky and J. C. Sadoff, “Advances in tuberculosis vaccine strategies,” Nature Reviews Microbiology, vol. 4, no. 6, pp. 469–476, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. I. M. Orme, “Development of new vaccines and drugs for TB: limitations and potential strategic errors,” Future Microbiology, vol. 6, no. 2, pp. 161–177, 2011. View at Publisher · View at Google Scholar
  12. P. Andersen, “TB vaccines: progress and problems,” Trends in Immunology, vol. 22, no. 3, pp. 160–168, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Pelizon, D. R. Martins, S. F. G. Zorzella et al., “Genetic vaccine for tuberculosis (pVAXhsp65) primes neonate mice for a strong immune response at the adult stage,” Genetic Vaccines and Therapy, vol. 5, article no. 12, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. L. de Paula, C. L. Silva, D. Carlos et al., “Comparison of different delivery systems of DNA vaccination for the induction of protection against tuberculosis in mice and guinea pigs,” Genetic Vaccines and Therapy, vol. 5, article no. 2, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. E. D. C. Gonçalves, V. L. Bonato, D. M. da Fonseca et al., “Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming,” Genetic Vaccines and Therapy, vol. 5, article no. 7, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. L. L. W. Ishikawa, T. G. D. França, F. Chiuso-Minicucci et al., “Dietary restriction abrogates antibody production induced by a DNA vaccine encoding the mycobacterial 65 kDa heat shock protein,” Genetic Vaccines and Therapy, vol. 7, article no. 11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. T. G. D. França, L. L. W. Ishikawa, S. F. G. Zorzella-Pezavento et al., “Immunization protected well nourished mice but not undernourished ones from lung injury in Methicillin-resistant Staphylococcus aureus (MRSA) infection,” BMC Microbiology, vol. 9, article no. 240, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Niiya, S. M. F. Akbar, O. Yoshida et al., “Impaired dendritic cell function resulting from chronic undernutrition disrupts the antigen-specific immune response in mice,” Journal of Nutrition, vol. 137, no. 3, pp. 671–675, 2007. View at Scopus
  19. M. Singh, M. L. Mynak, L. Kumar, J. L. Mathew, and S. K. Jindal, “Prevalence and risk factors for transmission of infection among children in household contact with adults having pulmonary tuberculosis,” Archives of Disease in Childhood, vol. 90, no. 6, pp. 624–628, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Sadeghi-Shabestari and N. Rezaei, “Disseminated bacille Calmette-Guérin in Iranian children with severe combined immunodeficiency,” International Journal of Infectious Diseases, vol. 13, no. 6, pp. e420–e423, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Nobrega, P. J. Cardona, S. Roque, P. Pinto do Ó, R. Appelberg, and M. Correia-Neves, “The thymus as a target for mycobacterial infections,” Microbes and Infection, vol. 9, no. 14-15, pp. 1521–1529, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Nobrega, S. Roque, C. Nunes-Alves et al., “Dissemination of mycobacteria to the thymus renders newly generated T cells tolerant to the invading pathogen,” Journal of Immunology, vol. 184, no. 1, pp. 351–358, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. J. L. Flynn, M. M. Goldstein, J. Chan et al., “Tumor necrosis factor-α is required in the protective immune response against mycobacterium tuberculosis in mice,” Immunity, vol. 2, no. 6, pp. 561–572, 1995. View at Scopus
  24. J. L. Flynn, J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom, “An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection,” Journal of Experimental Medicine, vol. 178, no. 6, pp. 2249–2254, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Hussey, T. Hawkridge, and W. Hanekom, “Childhood tuberculosis: old and new vaccines,” Paediatric Respiratory Reviews, vol. 8, no. 2, pp. 148–154, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. C. S. Merle, S. S. Cunha, and L. C. Rodrigues, “BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control,” Expert Review of Vaccines, vol. 9, no. 2, pp. 209–222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. C. Spencer, R. Ganguly, and R. H. Waldman, “Nonspecific protection of mice against influenza virus infection by local or systemic immunization with bacille Calmette-Guerin,” Journal of Infectious Diseases, vol. 136, no. 2, pp. 171–175, 1977. View at Scopus
  28. D. L. Sewell, E. K. Reinke, L. H. Hogan, M. Sandor, and Z. Fabry, “Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections,” Immunology Letters, vol. 82, no. 1-2, pp. 101–110, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Nikoopour, J. A. Schwartz, and B. Singh, “Therapeutic benefits of regulating inflammation in autoimmunity,” Inflammation and Allergy - Drug Targets, vol. 7, no. 3, pp. 203–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Bilenki, X. Gao, S. Wang et al., “Dendritic cells from mycobacteria-infected mice inhibits established allergic airway inflammatory responses to ragweed via IL-10- and IL-12-secreting mechanisms,” Journal of Immunology, vol. 184, no. 12, pp. 7288–7296, 2010. View at Publisher · View at Google Scholar · View at Scopus